SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
SEC Accession No. 0001193125-20-307950
Filing Date
2020-12-02
Accepted
2020-12-02 09:18:28
Documents
3

Document Format Files

Seq Description Document Type Size
1 SC 14D9/A d90208dsc14d9a.htm SC 14D9/A 19391
2 EX-99.(A)(5)(D) d90208dex99a5d.htm EX-99.(A)(5)(D) 10115
3 GRAPHIC g90208g002.jpg GRAPHIC 12193
  Complete submission text file 0001193125-20-307950.txt   47956
Mailing Address 2 RIGHTER PARKWAY, SUITE 200 WILMINGTON DE 19803
Business Address 35 WILBUR ST LYNBROOK NY 11563 302-842-8450
BIOSPECIFICS TECHNOLOGIES CORP (Filed by) CIK: 0000875622 (see all company filings)

IRS No.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2 RIGHTER PARKWAY, SUITE 200 WILMINGTON DE 19803
Business Address 35 WILBUR ST LYNBROOK NY 11563 302-842-8450
BIOSPECIFICS TECHNOLOGIES CORP (Subject) CIK: 0000875622 (see all company filings)

IRS No.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9/A | Act: 34 | File No.: 005-79091 | Film No.: 201362526
SIC: 2834 Pharmaceutical Preparations